Basic Information
| RNALocate ID: | RLID:11002797 |
| RNA Symbol: | hsa-miR-200a-5p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-200a-star |
| RNA ID: | miRBase:MIMAT0001620 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23539611 |
| Tissue/Cell Line: | Seminal plasma |
| Method: | Microarray |
| Description: | In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11002792 | Exosome | Peripheral blood | 31746410 |
| RLID:11002793 | Exosome | B cell line (Raji)|Jurkat-derived T cell line (J77cl20) | 21505438 |
| RLID:11002794 | Exosome | Breast milk | 22211110 |
| RLID:11002795 | Exosome | Brain tissue | 23382797 |
| RLID:11002796 | Exosome | Plasma | 23663360 |
| RLID-D:11000140 | Exosome | Colon tissue|Tongue tissue | |
| RLID-D:11000456 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-200a-5p | Large cell neuroendocrine cancer | MNDR-E-MI-25945 |
| MNDR | hsa-miR-200a-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-25946 |
| MNDR | hsa-miR-200a-5p | Ovarian clear cell carcinoma | MNDR-E-MI-25947 |
| MNDR | hsa-miR-200a-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-25948 |
| MNDR | hsa-miR-200a-5p | Lymphoma | MNDR-E-MI-25949 |
| MNDR | hsa-miR-200a-5p | Prostate cancer | MNDR-E-MI-25950 |
| MNDR | hsa-miR-200a-5p | Gastric cancer | MNDR-E-MI-25951 |
| MNDR | hsa-miR-200a-5p | Bladder cancer | MNDR-E-MI-25952 |
| MNDR | hsa-miR-200a-5p | Parkinson disease | MNDR-E-MI-25953 |
| MNDR | hsa-miR-200a-5p | Breast cancer | MNDR-E-MI-25954 |
| MNDR | hsa-miR-200a-5p | Thyroid cancer | MNDR-E-MI-25955 |
| MNDR | hsa-miR-200a-5p | Pituitary neoplasms | MNDR-E-MI-25956 |
| MNDR | hsa-miR-200a-5p | Pancreatic cancer | MNDR-E-MI-25957 |
| MNDR | hsa-miR-200a-5p | Rectum adenocarcinoma | MNDR-E-MI-25958 |
| MNDR | hsa-miR-200a-5p | Nephroblastoma | MNDR-E-MI-25959 |
| MNDR | hsa-miR-200a-5p | Colon cancer | MNDR-E-MI-25960 |
| MNDR | hsa-miR-200a-5p | Colon adenocarcinoma | MNDR-E-MI-25961 |
| MNDR | hsa-miR-200a-5p | Familial ovarian cancer | MNDR-E-MI-25962 |
| MNDR | hsa-miR-200a-5p | Carcinoma ductal breast | MNDR-E-MI-25963 |
| MNDR | hsa-miR-200a-5p | Invasive ductal carcinoma | MNDR-E-MI-25964 |
| MNDR | hsa-miR-200a-5p | Glioma | MNDR-E-MI-25965 |
| MNDR | hsa-miR-200a-5p | Breast carcinoma | MNDR-E-MI-25966 |
| MNDR | hsa-miR-200a-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-25967 |
| MNDR | hsa-miR-200a-5p | Cervical adenocarcinoma | MNDR-E-MI-25968 |
| MNDR | hsa-miR-200a-5p | Gastric adenocarcinoma | MNDR-E-MI-25969 |
| MNDR | hsa-miR-200a-5p | Cervical squamous cell carcinoma | MNDR-E-MI-25970 |
| MNDR | hsa-miR-200a-5p | Pituitary adenoma | MNDR-E-MI-25971 |
| MNDR | hsa-miR-200a-5p | Lung squamous cell carcinoma | MNDR-E-MI-25972 |
| MNDR | hsa-miR-200a-5p | Lung adenocarcinoma | MNDR-E-MI-25973 |
| MNDR | hsa-miR-200a-5p | Ovarian carcinoma | MNDR-E-MI-25974 |
| MNDR | hsa-miR-200a-5p | Bladder urothelial carcinoma | MNDR-E-MI-25975 |
| MNDR | hsa-miR-200a-5p | Pancreatic adenocarcinoma | MNDR-E-MI-25976 |
| MNDR | hsa-miR-200a-5p | Carcinoma renal cell | MNDR-E-MI-25977 |
| MNDR | hsa-miR-200a-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-25978 |
| MNDR | hsa-miR-200a-5p | Clear cell renal cell carcinoma | MNDR-E-MI-25979 |
| MNDR | hsa-miR-200a-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-25980 |
| MNDR | hsa-miR-200a-5p | Cholangiocarcinoma | MNDR-E-MI-25981 |
| MNDR | hsa-miR-200a-5p | Lung small cell carcinoma | MNDR-E-MI-25982 |
| MNDR | hsa-miR-200a-5p | Synovial sarcoma | MNDR-E-MI-25983 |
| MNDR | hsa-miR-200a-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-25984 |
| MNDR | hsa-miR-200a-5p | Testicular germ cell cancer | MNDR-E-MI-25985 |
| MNDR | hsa-miR-200a-5p | Breast invasive carcinoma | MNDR-E-MI-25986 |
| MNDR | hsa-miR-200a-5p | Hepatocellular carcinoma | MNDR-E-MI-25987 |
| MNDR | hsa-miR-200a-5p | Familiar ovarian carcinoma | MNDR-E-MI-25988 |
| MNDR | hsa-miR-200a-5p | Barrett's adenocarcinoma | MNDR-E-MI-25989 |
| MNDR | hsa-miR-200a-5p | Tonsil cancer | MNDR-E-MI-25990 |
| MNDR | hsa-miR-200a-5p | Skin cutaneous melanoma | MNDR-E-MI-25991 |
| MNDR | hsa-miR-200a-5p | Skin melanoma | MNDR-E-MI-25992 |
| MNDR | hsa-miR-200a-5p | Colorectal cancer | MNDR-E-MI-25993 |
| MNDR | hsa-miR-200a-5p | Barrett's carcinogenesis | MNDR-E-MI-25994 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | CTNNB1 | Homo sapiens | RR00378128 |
TOP